Marsh (MRSH) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
17 Jun, 2026Executive summary
Achieved 6% GAAP revenue growth and 5% underlying revenue growth in Q3 2024, with strong execution in Risk & Insurance Services and Consulting.
Adjusted operating income grew 12% and adjusted operating margin expanded by 110 basis points year-over-year.
Announced $7.75 billion acquisition of McGriff Insurance Services, expected to close by year-end and be modestly accretive to adjusted EPS in year one.
Year-to-date, nearly $10 billion of capital committed to acquisitions, marking the largest M&A year in company history.
Achieved $23.9 billion in revenue for the 12 months ended 9/30/2024, with operations in 130 countries and over 85,000 employees.
Financial highlights
Q3 consolidated revenue increased 6% to $5.7 billion; underlying growth was 5%.
Q3 operating income was $1.1 billion, up 11%; adjusted operating income was $1.2 billion, up 12%.
Adjusted EPS for Q3 was $1.63, up 4% year-over-year, or 11% excluding a discrete tax benefit last year.
For the first nine months, underlying revenue grew 7%, adjusted operating income grew 12% to $4.9 billion, and adjusted EPS increased 10% to $6.93.
Free cash flow reached $3.8 billion for the last twelve months ended Q3 2024.
Outlook and guidance
Expect mid-single-digit or better underlying revenue growth, margin expansion, and strong adjusted EPS growth for full year 2024, assuming current macro conditions persist.
Plan to deploy approximately $4.2 billion of capital in 2024 across dividends, acquisitions, and share repurchases.
Plan to pause share repurchases in Q4 due to the McGriff acquisition, but expect to maintain a balanced capital management approach in 2025.
Latest events from Marsh
- Revenue hit $27B, AI and acquisitions drove growth, and all voting items passed.MRSH
AGM 202621 May 2026 - Q1 2026 revenue and adjusted EPS grew 8%, but legal charges weighed on GAAP results.MRSH
Q1 202623 Apr 2026 - Annual meeting to vote on directors, executive pay, and auditor ratification, all board-backed.MRSH
Proxy filing31 Mar 2026 - Strong 2025 results, robust governance, and high say-on-pay support highlight this proxy filing.MRSH
Proxy filing31 Mar 2026 - 2025 revenue up 10%, adjusted EPS up 9%, and $2.0B in share repurchases.MRSH
Q4 202527 Feb 2026 - Q2 revenue up 6%, EPS up 10%, margin 29%, and dividend raised 15% amid robust growth.MRSH
Q2 20243 Feb 2026 - Strong 2024 growth, record acquisitions, and margin expansion set up a positive 2025 outlook.MRSH
Q4 20249 Jan 2026 - Q1 2025 revenue up 9%, adjusted EPS up 5%, with strong segment growth and capital returns.MRSH
Q1 202519 Dec 2025 - Strong 2024 results, robust governance, and key votes on directors, pay, auditor, and equity plan.MRSH
Proxy Filing1 Dec 2025